National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$69.95
add to cart

Rights & Permissions

topleft topright

Dietary Reference Intakes for Calcium and Vitamin D (2011)
Food and Nutrition Board (FNB)

Citation Manager

. "4 Review of Potential Indicators of Adequacy and Selection of Indicators: Calcium and Vitamin D." Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press, 2011.

Please select a format:

BibTeX EndNote RefMan


Page
281
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


DRI Dietary Reference Intakes Calcium Vitamin D

until weeks or months after birth (Begum et al., 1968; Ford et al., 1973; Moncrieff and Fadahunsi, 1974; Sann et al., 1976; Pereira and Zucker, 1986; Park et al., 1987; Campbell and Fleischman, 1988; Specker, 1994; Teotia et al., 1995; Beck-Nielsen et al., 2009). Thus, neonatal rickets is of limited utility in the development of DRIs for pregnancy.

  • Maternal and cord blood 25OHD levels Regarding pregnancy outcomes, maternal and cord blood 25OHD levels may be of interest. AHRQ-Ottawa reported inconsistent evidence on changes in serum 25OHD levels during pregnancy, with two studies reporting no change and one study reporting a decline. In a few other studies, maternal serum 25OHD levels have responded to supplemental vitamin D (Marya et al., 1981, 1988; Mallet et al., 1986; Yu et al., 2009). In observational studies, babies born of vitamin D–deficient mothers have the lowest serum 25OHD levels and are at higher risk for complications sooner after birth than are babies born of vitamin D–replete mothers. Maternal serum 25OHD levels were stable and largely unaffected by pregnancy (Hillman et al., 1978; Brooke et al., 1980; Ardawi et al., 1997; Morley et al., 2006), even when the baseline serum 25OHD level was very low (20.1 ± 1.9 nmol/L) (Brooke et al., 1980).

Overall, fetal BMC and related skeletal outcomes are informative for DRI development for pregnancy.


POTENTIAL INDICATORS FOR LACTATION: CALCIUM The key physiological changes to meet the calcium demands of lactation occur through increased bone resorption, and most of the calcium in human milk comes from the maternal skeleton (Kalkwarf, 1999; Prentice, 2003; Kovacs, 2005; Kovacs and Kronenberg, 2008). Thus, lactation is a period of transient bone mineral loss and not, per se, a period of bone maintenance, although BMD is restored post-weaning (Kalkwarf, 1999). However, lactation is included in the category of bone maintenance in order to discuss pregnancy and lactation contiguously, and because bone mineral is restored in the immediate period post-lactation. Potential indicators related to calcium requirements during lactation are outlined below.

  • Maternal BMD The need to provide calcium to the infant—a need that is two to three times greater than the daily amount needed for fetal development during pregnancy—is met by the maternal adaptation of increased bone resorption (Specker et al., 1994; Kalkwarf et al., 1997), resulting in a 5 to 10 percent decline in BMD during the first 6 months of exclusive breastfeeding

Page
281
Front Matter (R1-R16)
Summary (1-14)
1 Introduction (15-34)
2 Overview of Calcium (35-74)
3 Overview of Vitamin D (75-124)
4 Review of Potential Indicators of Adequacy and Selection of Indicators: Calcium and Vitamin D (125-344)
5 Dietary Reference Intakes for Adequacy: Calcium and Vitamin D (345-402)
6 Tolerable Upper Intake Levels: Calcium and Vitamin D (403-456)
7 Dietary Intake Assessment (457-478)
8 Implications and Special Concerns (479-512)
9 Information Gaps and Research Needs (513-522)
Appendix A: Acronyms, Abbreviations, and Glossary (523-536)
Appendix B: Issues and Interests Identified by Study Sponsors (537-538)
Appendix C: Methods and Results from the AHRQ-Ottawa Evidence-Based Report on Effectiveness and Safety of Vitamin D in Relation to Bone Health (539-724)
Appendix D: Methods and Results from the AHRQ-Tufts Evidence-Based Report on Vitamin D and Calcium (725-1012)
Appendix E: Literature Search Strategy (1013-1018)
Appendix F: Evidence Maps (1019-1024)
Appendix G: Cases Studies of Vitamin D Toxicity (1025-1034)
Appendix H: Estimated Intakes of Calcium and Vitamin D from National Surveys (1035-1044)
Appendix I: Proportion of the Population Above and Below 40 nmol/L Serum 25-Hydroxyvitamin D Concentrations and Cumulative Distribution of Serum 25-Hydroxyvitamin D Concentrations: United States and Canada (1045-1058)
Appendix J: Workshop Agenda and Open Session Agendas (1059-1064)
Appendix K: Biographical Sketches of Committee Members (1065-1074)
Index (1075-1102)
Summary Tables: Dietary Reference Intakes (1103-1116)